Secondary adrenal insufficiency screening: Difference between revisions
Line 17: | Line 17: | ||
*There is insufficient evidence to recommend routine screening for secondary adrenal insufficiency. | *There is insufficient evidence to recommend routine screening for secondary adrenal insufficiency. | ||
==References== | ==References== |
Revision as of 12:56, 5 October 2017
Adrenal insufficiency Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Secondary adrenal insufficiency screening On the Web |
American Roentgen Ray Society Images of Secondary adrenal insufficiency screening |
Risk calculators and risk factors for Secondary adrenal insufficiency screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
- There is insufficient evidence to recommend routine screening for secondary adrenal insufficiency.
References
1. "hypopituitary". WebMD. 2006.
2. http://www.endotext.org/adrenal/adrenal13/adrenal13.htm
3. "Causes of secondary and tertiary adrenal insufficiency in adults". Retrieved 10 November 2016.
4. Rogoff JM, Stewart GN. THE INFLUENCE OF ADRENAL EXTRACTS ON THE SURVIVAL PERIOD OF ADRENALECTOMIZED DOGS. Science. 1927 Oct 7;66(1710):327–328. [PubMed]
5. Betterle C, Morlin L. Autoimmune Addison’s disease. In: Ghizzoni L, Cappa M, Chrousos G, Loche S, Maghnie M, eds. Pediatric Adrenal Diseases. Endocrine Development. Vol. 20. Padova, Italy: Karger Publishers; 2011: 161–172.
6. Neary N, Nieman L. Adrenal insufficiency: etiology, diagnosis and treatment. Current Opinion in Endocrinology, Diabetes and Obesity. 2010;(3):217–223
7. Arlt W, Allolio B. Adrenal insufficiency. Lancet. 2003 May 31. 361(9372):1881-93. [Medline].
8. Besser GM, Thorner MO. Adrenal insufficiency. Clinical Endocrinology. St Louis, Mo: Mosby-Year Book; 1996. [CD-ROM] 9. Purandare A, Godil MA, Prakash D, Parker R, Zerah M, Wilson TA. Spontaneous adrenal hemorrhage associated with transient antiphospholipid antibody in a child. Clin Pediatr (Phila). 2001 Jun. 40(6):347-50. [Medline].
10. Olafsson AS, Sigurjonsdottir HA. INCREASING PREVALENCE OF ADDISON DISEASE: RESULTS FROM A NATIONWIDE STUDY. Endocr Pract. 2016 Jan. 22 (1):30-5. [Medline].
11. Kyriazopoulou V. Glucocorticoid replacement therapy in patients with Addison's disease. Expert Opin Pharmacother. 2007 Apr. 8(6):725-9. [Medline].
12. Bergthorsdottir R, Leonsson-Zachrisson M, Oden A, et al. Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab. 2006 Dec. 91(12):4849-53. [Medline]. [Full Text]
13. White K, Arlt W. Adrenal crisis in treated Addison's disease: a predictable but under-managed event. Eur J Endocrinol. 2010 Jan. 162(1):115-20. [Medline].
14. Hemminki K, Li X, Sundquist J, et al. Subsequent autoimmune or related disease in asthma patients: clustering of diseases or medical care?. Ann Epidemiol. 2010 Mar. 20(3):217-22.
15. Chantzichristos D, Persson A, Eliasson B, et al. Mortality in patients with diabetes mellitus and Addison's disease: a nationwide, matched, observational cohort study. Eur J Endocrinol. 2017 Jan. 176 (1):31-9. [Medline].
16. Hardy K J, Burge M R, Boyle P J. et al A treatable cause of recurrent severe hypoglycaemia. Diabetes Care 199417722–724. [PubMed]
17. Phornphutkul C, Boney C M, Gruppuso P A. A novel presentation of Addison disease: hypoglycemia unawareness in an adolescent with insulin‐dependent diabetes mellitus. J Pediatr 1998132882–884.[PubMed]